An Unsettling Precedent: US “Section 232” Probe into Medical Devices Alarms EU

An unsettling precedent is being set in Washington that has alarmed the European Union, as the US opens a “section 232” investigation into imported medical devices. This type of probe, which assesses whether imports threaten national security, is the same tool the Trump administration previously used to justify tariffs on steel and aluminum, and it is widely seen as a clear signal that new duties are on the way.
The EU has good reason to be worried. It is a massive exporter of medical devices to the US, with products ranging from everyday essentials like catheters to life-saving technologies like pacemakers, stents, and X-ray machines. Tariffs on these goods would not only hurt European manufacturers but could also disrupt the US healthcare system by raising costs and potentially creating shortages.
This new investigation opens another front in the escalating trade war at a time when Europe is already dealing with tariff threats on multiple other products. It suggests that no sector is off-limits and that the US is prepared to use the powerful, and controversial, justification of “national security” to protect a wide range of domestic industries.
The move also serves to undermine the EU’s confidence in its existing 15% blanket tariff agreement with the US. While that deal was meant to be an “insurance policy” against new tariffs, the section 232 probe is a separate legal mechanism that could allow the administration to bypass the agreement entirely.
As European officials and industry leaders monitor the investigation’s progress, a sense of dread is growing. The probe into medical devices is more than just a procedural step; it’s a clear indication that the trade conflict is likely to deepen and expand, setting a troubling precedent for the future of international commerce.